Search

everythinglearnresearchcommunity

for

Search:↓

Vitamin D deficiency is common in women with PCOS and linked to some metabolic problems, but not the main cause of their metabolic issues.

Eating a balanced diet with specific nutrients is important for menopausal women to manage hair loss.

Skin diseases linked to insulin resistance should be managed to prevent diabetes and reduce heart disease risk.

Both injectable contraceptives lower testosterone and SHBG levels, with NET-EN having a greater effect than DMPA-IM.

The method accurately measures sex hormones in human plasma but can have small errors.

Women with hyperandrogenism have higher androgen levels and lower SHBG, which may contribute to conditions like excessive hair growth and early puberty.

Excess maternal androgens can cause heart problems in offspring.

Sex hormones likely don't affect atopic dermatitis in adolescents and adults.

Hormonal imbalances during menopause may significantly contribute to Frontal Fibrosing Alopecia.

Some supplements and hormones can increase hair loss by raising DHT levels.

The levonorgestrel implant increases free testosterone and lowers SHBG more than DMPA-IM and the copper IUD.

Testosterone treatment may change estrogen receptor methylation in AFAB individuals.

Creating evidence-based guidelines for gender incongruence is difficult due to the personalized nature of transgender medicine.

COVID-19 may harm male fertility and damage the reproductive system.

The document concludes that health care providers should offer culturally competent care and more research is needed to improve health outcomes for transgender individuals.

Women with PCOS often have irregular periods, a higher chance of infertility and miscarriages, and may improve fertility with lifestyle changes and treatment.

Menopausal acne is treated with medications and lifestyle changes, but careful choice is needed due to side effects.

More research is needed to understand how testosterone is maintained in adult males.

The HairCheck® device is effective for measuring hair loss and growth in people with alopecia.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

Nuclear hormone receptors play a significant role in skin wound healing and could lead to better treatment methods.

Some plant-based treatments may help with ovary function, insulin resistance, and excess male hormones in PCOS, but more research is needed to confirm their safety and effectiveness.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

The document concludes that future heart disease research should account for sex-specific differences to improve diagnosis, treatment, and outcomes.

The document concludes that there is a significant lack of reporting on the sex and age of cells in skin research, which could affect clinical trials and treatments.

Androgens block hair growth by disrupting cell signals; targeting GSK-3 may help treat hair loss.

Hormone therapy in transgender individuals can increase acne and affect hair growth and loss.

Antiandrogens can help treat skin conditions like acne and excessive hair in women when used carefully.

Early-onset hair loss in Egyptian males is linked to genetics, hormones, and lifestyle factors like smoking and diet.

Early diagnosis and treatment with Leuprolide are key for children with precocious puberty.